Cerner Recognized by KLAS for Growth in Population Health Management

KANSAS CITY, Mo., July 24, 2015 (GLOBE NEWSWIRE) -- Cerner, a global leader in health care technology, has been recognized as "a supplier most considered for future population health management (PHM) capabilities," according to a recent KLAS report.

The report, Population Health Management Perception 2015: Which Vendors Stand Out, identifies Cerner as one of two vendors expected to see the highest growth in PHM in the coming years as electronic medical record (EMR) clients seek to lower PHM costs and increase EMR workflow integration.

Forty-one percent of the 112 providers surveyed said they are looking to replace a risk or care management solution. In the report, an anonymous client explained why they made the decision to switch to Cerner.

"We are moving to Cerner because of their integration with our inpatient EMR and because of some of the efforts they are making around building ambulatory workflows for care management."

Cerner's PHM suite of solutions leverages HealtheIntent(SM), a system-agnostic, near real-time data platform that normalizes data from any source, facilitates the discovery of new knowledge and creates a continuous learning environment.

Cerner has experienced increased demand for HealtheIntent and has 65 unique clients and counting, several of which have aligned their PHM strategies with HealtheIntent including Stony Brook Clinical Network LLC.

"Stony Brook Clinical Network LLC has selected HealtheIntent to manage the population for our Suffolk County Performing Provider System, part of the New York State Delivery System Reform Incentive Payment Program," said Jim Murry, CIO, Stony Brook Clinical Network LLC. "With HealtheIntent solutions, our care providers will be enabled to make more informed decisions at the point of care to promote better outcomes, a better patient experience and continuous knowledge through access to multi-system data."

More than 40 thousand jobs are processed by the HealtheIntent platform daily, touching more than 40 million unique lives.

"To have a comprehensive approach to population health management, it's vital for members to be engaged in their own health and care," said Matthew Swindells, SVP, population health, Cerner. "We're pleased with the rapid adoption of our agnostic population health management solutions by existing clients, non-Cerner clients and government clients. We believe the key to successful adoption is Cerner's ability to normalize data in near real-time from disparate systems and create actions for providers and individuals, effectively enabling providers to manage the health of their populations."

About Cerner
Cerner's health information technologies connect people, information and systems at more than 18,000 facilities worldwide. Recognized for innovation, Cerner solutions assist clinicians in making care decisions and enable organizations to manage the health of populations. The company also offers an integrated clinical and financial system to help health care organizations manage revenue, as well as a wide range of services to support clients' clinical, financial and operational needs.

Cerner's mission is to contribute to the systemic improvement of health care delivery and the health of communities. On February 2, 2015, Cerner Corporation acquired substantially all of the assets, and assumed certain liabilities, of the Siemens Health Services business from Siemens AG. Nasdaq: CERN. For more information about Cerner, visit cerner.com.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.